Comparison of 18F FDOPA PET, DSC-MRI and spectroscopy in a patient with brain metastatic lesions from lung cancer

Rev Esp Med Nucl Imagen Mol. 2016 May-Jun;35(3):207-8. doi: 10.1016/j.remn.2015.06.003. Epub 2015 Sep 14.

[Article in English, Spanish]

Authors

A Chiaravalloti¹, R Floris², O Schillaci³

Affiliations

¹ IRCCS Neuromed, Pozzilli, Italy. Electronic address: [email protected].
² Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.
³ IRCCS Neuromed, Pozzilli, Italy; Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.

PMID: 26382765
DOI: 10.1016/j.remn.2015.06.003

No abstract available

Publication types

Case Reports
Comparative Study

MeSH terms

Adenocarcinoma / diagnostic imaging*
Adenocarcinoma / secondary
Brain Neoplasms / diagnostic imaging*
Brain Neoplasms / secondary
Contrast Media
Dihydroxyphenylalanine
Fluorodeoxyglucose F18
Humans
Lung Neoplasms / pathology*
Magnetic Resonance Imaging / methods*
Magnetic Resonance Spectroscopy*
Meglumine / analogs & derivatives
Organometallic Compounds
Positron Emission Tomography Computed Tomography*
Radiopharmaceuticals
Spectrum Analysis

Substances

Contrast Media
Organometallic Compounds
Radiopharmaceuticals
Fluorodeoxyglucose F18
gadobenic acid
Dihydroxyphenylalanine
Meglumine